Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-resistant tuberculosis.

M D Iseman1, L A Madsen

  • 1Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado.

Clinics in Chest Medicine
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Zn2+ and water on the transport properties of a pyrrolidinium dicyanamide ionic liquid.

The journal of physical chemistry. B·2014
Same author

Uniaxial and biaxial nematic liquid crystals.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2006
Same author

Observation of force-detected nuclear magnetic resonance in a homogeneous field.

Proceedings of the National Academy of Sciences of the United States of America·2004
Same author

Thermotropic biaxial nematic liquid crystals.

Physical review letters·2004
Same author

A new approach to treating patients with MDR-TB?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2003
Same author

Tuberculosis therapy: past, present and future.

The European respiratory journal. Supplement·2002
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Multiply resistant tuberculosis is a growing global threat, especially in low-income countries. In the US, aggressive treatment combining chemotherapy and surgery offers the best cure for these challenging cases.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Multiply resistant tuberculosis (TB) is a significant and escalating global health concern.
  • The spread of drug-resistant tubercle bacilli poses a critical challenge to effective TB control worldwide.

Observation:

  • Economically limited nations face a heightened risk of untreatable tuberculosis due to rising resistance.
  • Resistant strains of tubercle bacilli can spread exponentially, exacerbating the public health crisis.

Findings:

  • In the United States, aggressive chemotherapy is the primary treatment strategy for multiply resistant tuberculosis.
  • Surgical intervention is recommended for localized cases of multiply resistant tuberculosis, enhancing the prospects for cure.

Related Experiment Videos

Implications:

  • Effective management strategies are crucial to combat the spread of drug-resistant tuberculosis globally.
  • Continued research and implementation of aggressive treatment protocols are vital for improving patient outcomes and controlling resistant TB strains.